Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
July 25 2024 - 8:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a
leading provider of biosimulation, simulation-enabled performance
and intelligence solutions, and medical communications for the
biopharma industry, today announced that Shawn O’Connor, chief
executive officer, will attend KeyBanc Capital Markets’ 25th Annual
Technology Leadership Forum on Monday, August 5, 2024, in Vail,
Colorado. In addition to hosting one-on-one meetings throughout the
day, Mr. O’Connor will join a panel discussion entitled “AI and
Digital Solutions for Drug Discovery” followed by a 25-minute
Fireside Chat at 1:30 p.m. MDT (3:30 p.m. EDT).
The live audio webcast of Mr. O’Connor’s Fireside Chat can be
accessed via this link and also on the Investors page of the
Simulations Plus website where the replay will be available for 90
days following the event.
About Simulations Plus
With more than 25 years of experience serving clients globally,
Simulations Plus stands as a premier provider in the biopharma
sector, offering advanced software and consulting services that
enhance drug discovery, development, research, clinical trial
operations, regulatory submissions, and commercialization. Our
comprehensive biosimulation solutions integrate artificial
intelligence/machine learning (AI/ML), physiologically based
pharmacokinetics, quantitative systems pharmacology/toxicology, and
population PK/PD modeling approaches. We also deliver
simulation-enabled performance and intelligence solutions alongside
medical communications support for clinical and commercial drug
development. Our cutting-edge technology is licensed and utilized
by leading pharmaceutical, biotechnology, and regulatory agencies
worldwide. For more information, visit our website at
www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts
where we can have the most positive impact. To learn more about our
latest initiatives and priorities, please visit our website to read
our 2023 ESG update.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725922663/en/
Simulations Plus Investor Relations
Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com
Financial Profiles Lisa Fortuna
310-622-8251 slp@finprofiles.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Jul 2023 to Jul 2024